Waltraut Kopp

Goettingen, NI, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells.

Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells.

Journal: Cell death & disease
Published: April 30, 2025

Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer.

Glucocorticoid receptor suppresses GATA6-mediated RNA polymerase II pause release to modulate classical subtype identity in pancreatic cancer.

Journal: Gut
Published: November 18, 2024

An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies.

An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies.

Journal: Gastroenterology
Published: February 13, 2023

Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer.

Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer.

Journal: Gut
Published: June 28, 2022

TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer.

TP53-Status-Dependent Oncogenic EZH2 Activity in Pancreatic Cancer.

Journal: Cancers
Published: June 09, 2022

HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells.

HSP90 Inhibition Synergizes with Cisplatin to Eliminate Basal-like Pancreatic Ductal Adenocarcinoma Cells.

Journal: Cancers
Published: November 02, 2021

Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer.

Chromatin-Independent Interplay of NFATc1 and EZH2 in Pancreatic Cancer.

Journal: Cells
Published: October 31, 2021

STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic Cancer.

STIM1 Mediates Calcium-Dependent Epigenetic Reprogramming in Pancreatic Cancer.

Journal: Cancer research
Published: August 21, 2020

EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6.

EZH2 Regulates Pancreatic Cancer Subtype Identity and Tumor Progression via Transcriptional Repression of GATA6.

Journal: Cancer research
Published: February 28, 2020

Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.

Interferon-λ4 (IFNL4) transcript expression in human liver tissue samples.

Journal: PloS one
Published: October 28, 2013
Showing 1-10 of 10

Last Updated: 09/26/2026